Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Cardiovascular disease is currently not adequately managed and has become one of the main causes of morbidity and mortality worldwide. Current therapies are inadequate in terms of preventing its progression. There are several limitations, such as poor oral bioavailability, side effects, low adherence to treatment, and high dosage frequency of formulations due to the short half-life of the active ingredients used, among others. This review aims to highlight the most relevant aspects of the relationship between the cardiovascular system and the endocannabinoid system, with special attention to the possible translational effect of the use of anandamide in cardiovascular health. The deep and detailed knowledge of this interaction, not always beneficial, and that for years has gone unnoticed, is essential for the development of new therapies. We discuss the most recent and representative results obtained in the field of basic research, referring to the aforementioned subject, emphasizing fundamentally the main role of nitric oxide, renal physiology and its deregulation in pathological processes.
Funding Information
  • Secretaría de Ciencia, Técnica y Postgrado de la UN de Cuyo, Mendoza, Argentina
  • Fondo para la Investigación Científica y Tecnológica (PICT 0234-2012 OC/AR BID 2777)

This publication has 69 references indexed in Scilit: